Laboratório de Biotecnologia Viral, Instituto Butantan, Av. Vital Brasil 1500, São Paulo, SP, CEP 05503-900, Brazil.
Laboratório Multipropósito, Instituto Butantan, Av. Vital Brasil 1500, São Paulo, SP, CEP 05503-900, Brazil.
Mol Biotechnol. 2023 Jun;65(6):970-982. doi: 10.1007/s12033-022-00586-x. Epub 2022 Nov 18.
This work aimed to describe the dynamics of the Sf9 insect cells death and primary metabolism when this host is infected simultaneously by two recombinant baculoviruses (BV) expressing rabies glycoprotein (BVG) and matrix protein (BVM) genes to produce rabies virus-like particles (VLP) at different multiplicities of infection (MOI). Schott flasks essays covering a wide range of MOI for both BV were performed. Viable cell density, cell viability, glucose, glutamine, glutamate, lactate, ammonium, and rabies proteins concentrations were monitored over the infection phase. The expression of both recombinant proteins was not limited by glucose, glutamine, and glutamate in a broad MOI (pfu/cell) range of BVG (0.15-12.5) and BVM (0.1-5.0) using SF900 III serum free culture medium. Death phase initiation and the specific death rate depend on BV MOI. The wave pattern of nutrient/metabolite profiles throughout the viral infection phase is related to the baculovirus lytic cycle. The optimal MOIs ratio between BVG (2.5-4.5) and BVM (1.0-3.0) for maximum protein expression was defined. The produced rabies VLP sizes are close to 78 nm. In general, these work outputs bring a better understanding of the metabolic performance of Sf9 cells when infected by BV for producing VLP, and specifically, for progressing in a rabies VLP vaccine development.
本研究旨在描述 Sf9 昆虫细胞在同时感染两种表达狂犬病糖蛋白(BVG)和基质蛋白(BVM)基因的重组杆状病毒(BV)时的死亡和初级代谢动力学,以生产狂犬病病毒样颗粒(VLP)在不同感染复数(MOI)下。进行了涵盖两种 BV 广泛 MOI 的 Schott 瓶实验。在感染阶段监测了活细胞密度、细胞活力、葡萄糖、谷氨酰胺、谷氨酸、乳酸、铵和狂犬病蛋白浓度。使用 SF900 III 无血清培养基,在广泛的 BVG(0.15-12.5)和 BVM(0.1-5.0)pfu/cell MOI 范围内,两种重组蛋白的表达不受葡萄糖、谷氨酰胺和谷氨酸的限制。死亡阶段的开始和特定死亡率取决于 BV MOI。整个病毒感染阶段的营养/代谢物谱的波动模式与杆状病毒裂解周期有关。确定了 BVG(2.5-4.5)和 BVM(1.0-3.0)之间最大蛋白表达的最佳 MOI 比值。产生的狂犬病 VLP 大小接近 78nm。总的来说,这些工作结果更好地了解了 Sf9 细胞在感染 BV 生产 VLP 时的代谢表现,特别是在狂犬病 VLP 疫苗开发方面。